Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV-exposed, uninfected youth
- PMID: 31385616
- PMCID: PMC6800591
- DOI: 10.1111/jcpe.13179
Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV-exposed, uninfected youth
Abstract
Aim: To examine oral biomarkers that have been associated with periodontal disease progression in HIV-infected adults in perinatally HIV-infected and HIV-exposed but uninfected youth.
Material and methods: This was a cross-sectional, multicentre substudy of youth participating in the Oral Health Pediatric HIV/AIDS Cohort study. Gingival crevicular fluid repository samples from participants with and without periodontal disease (using Gingival Index [GI] and Bleeding on Probing [BOP] parameters on dental examination) were tested for concentration levels of inflammatory biomarkers. Associations were assessed using Wilcoxon test and Spearman correlation.
Results: For perinatal HIV youth (n = 129), the markers consistently elevated (p < .05) in sites with GI ≥2 and in sites with BOP were interleukin-1β, 6 and 13, macrophage inflammatory protein-1α and metalloproteinase-9. Serum tumour necrosis factor-α and soluble CD14 were positively correlated with a summary count of elevated cytokines. No associations were seen among HIV-uninfected subjects (n = 71).
Conclusions: The association of oral biomarkers of inflammation with clinical indicators of periodontal inflammation and systemic immune activation suggests that perinatal HIV-infected youth may be at higher risk for developing significant periodontal disease, associated with tooth loss and HIV progression. More frequent dental care of this group is needed to prevent potential periodontal progression.
Keywords: cytokines; oral health; perinatal HIV-infected youth; periodontal inflammation.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
Figures


References
-
- Ainamo J & Bay I (1975) Problems and proposals for recording gingivitis and plaque. International Dental Journal 25, 229–235. - PubMed
-
- Alpagot T, Font K & Lee A (2003) Longitudinal evaluation of GCF IFN-gamma levels and periodontal status in HIV+ patients. Journal of Clinical Periodontology 30, 944–948. - PubMed
-
- Alpagot T, Suzara V & Bhattacharyya M (2006) The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients. Journal of Periodontal Research 41, 491–497. doi:10.1111/j.1600-0765.2006.00887.x. - DOI - PubMed
-
- Alperen J, Brummel S, Tassiopoulos K, Mellins CA, Kacanek D, Smith R, Seage GR 3rd & Moscicki AB (2014) Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth. Journal of Adolescent Health 54, 341–349. doi:10.1016/j.jadohealth.2013.09.003. - DOI - PMC - PubMed